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Abstract 
Postpartum depression screening guidelines were updated by the American College of 
Obstetricians and Gynecologists and the United States Preventive Services Task Force in 2015 
and 2016, respectively.  Universal postpartum depression screening is recommended where 
previously it was not.  Postpartum depression screening is relevant to the rapidly growing 
population of women Veterans served by the Veterans Health Administration (VA) as part of 
their comprehensive health care benefits.  Little information was available on the postpartum 
depression screening practices within the Alaska VA Healthcare System.  Using a quality 
improvement methodology, the author identified postpartum depression screening as a topic of 
interest.  Current practice was assessed through a retrospective chart audit of all maternity 
consults placed during the fiscal year 2014.  The chart audit revealed an 81% postpartum 
depression screening rate.  Incomplete data limited a full statistical analysis; however, all women 
who returned to an Alaska VA clinic, received screening and treatment.  An informational 
brochure was developed for women and their health care providers highlighting postpartum 
depression screening and treatment resources.   
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Postpartum Depression Screening of Women Veterans in Alaska: 
Quality Improvement Project 
Postpartum depression (PPD) screening clinical guidelines were recently updated.  In 
2016, the United States Preventive Services Task Force (USPSTF) updated its recommendations 
on screening for depression in adults.  Pregnant and postpartum women are specifically 
identified in the target population, where the previous recommendations excluded pregnant 
women and did not address the postpartum period (Siu & USPSTF, 2016; USPSTF, 2009).  The 
American College of Obstetricians and Gynecologists (ACOG) previously did not recommend 
universal screening for depression in pregnancy and the postpartum period (ACOG, 2010).  As 
of 2015,  recommendations include screening all patients at least once in the perinatal period for 
depression and anxiety (ACOG, 2015). 
Depression is a significant condition in the female Veteran population.  It was the most 
common condition for which women ages 18-44 years sought care at the Department of Veterans 
Affairs Veterans Health Administration (VA) during the fiscal year (FY) 2012 (Frayne et al., 
2014).  The number of women seeking services from VA for maternity care also increased from 
351 deliveries in FY 2000 to over 2,000 deliveries in FY 2010 (Zephyrin et al., 2014).  
Reviewing the Women Veterans Health Care website, there is information on depression, but 
none on PPD. With the update in recommendations and growing population served, this was an 
appropriate time to step back and evaluate current practice on PPD screening in the Alaska VA 
Healthcare System (AVAHS).   
Prevalence of Postpartum Depression 
The estimated prevalence of PPD is widely varied depending on the method of screening, 
scoring criteria, and postpartum timeframe.  Researchers agree it frequently occurs enough to 
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warrant screening.  Interestingly, self-reported symptoms yielded lower rates than formal 
screening.  Table 1 lists prevalence results from studies of postpartum women. 
 
Table 1 
Prevalence of Postpartum Depression 
Source Prevalence Screening tool 
Postpartum 
timeframe Sample 
Alcorn, 
O’Donovan, 
Patrick, Creedy, 
& Devilly, 2010 
22.1%  
27.0%  
27.2% 
EPDS 4-6 weeks        
3 months         
6 months 
886 women in Australia 
Balbierz, Bodnar-
Deren, Wang, & 
Howell, 2015 
8% EPDS 3 months 945 women from large 
tertiary inner-city hospital 
in New York City 
Beck, Gable, 
Sakala, & 
Declercq, 2011 
63%        
42% 
PDSS-short form 
PHQ-2 
1-12 months   
7-18 months 
1573 women nationally  
902 women nationally 
CDC, 2015 11.7% Self-reported 
frequent PPD 
symptoms 
2-6 months 37,090 women nationally 
CDC, 2015 7.4% Self-reported 
frequent PPD 
symptoms 
2-6 months 1,106 women in Alaska 
Mattocks et al., 
2010a 
32% ICD-9 code for 
pregnancy & 
mental health 
condition 
unreported 2966 women Veterans 
nationally 
Nguyen et al., 
2013 
11% PHQ-9 unreported 1,660 U. S. Active Duty 
Servicewomen 
Schachman & 
Lindsey, 2013 
50.7% PDSS-short form 8 weeks 71 military wives in 
southeast U. S. 
Yawn et al., 2009 28.7%  
18.7% -
43.7% 
EPDS            
PHQ-9 
5-12 weeks 481 women nationally 
Note. EPDS = Edinburgh Postnatal Depression Scale; CDC = Centers for Disease Control and Prevention; PDSS = Postpartum 
Depression Screening Scale; PHQ-2 = Patient Health Questionnaire two question form; ICD-9 = International Classification of 
Diseases, Ninth revision; PHQ-9 = Patient Health Questionnaire 
aData not specific to PPD; includes major and minor depression, bipolar disorder, post-traumatic stress disorder, schizophrenia, 
and anxiety disorder.
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U. S. Preventive Services Task Force (USPSTF) 
 The USPSTF is an independent, volunteer panel of national experts in prevention and 
evidence-based medicine.  The professional background of the panelists includes internal 
medicine, family practice, pediatrics, behavioral health, obstetrics and gynecology, and nursing.  
Created in 1984, the task force has convened annually since 1998 through acts of Congress.  The 
panel members produce evidence-based recommendations on screenings, counseling services, 
and preventive medications to improve the health of all Americans (USPSTF, 2016). 
American College of Obstetricians and Gynecologists (ACOG) 
 ACOG is a 501(c)(3) organization dedicated to the improvement of women’s health since 
founded in 1951.  It is the specialty’s premier professional membership organization with over 
57,000 members (ACOG, 2016).  The members develop practice bulletins, committee opinions, 
and other educational materials for obstetric and gynecologic professionals.  The committee 
opinion on perinatal depression screening was written by ACOG’s Committee on Obstetric 
Practice.  The committee consists of 15 appointed, actively practicing, obstetric physicians and 
meets twice annually.   
Veterans Health Administration (VA) 
 The Veterans Health Administration is America’s largest integrated health care system 
providing comprehensive care to more than 8.3 million Veterans annually.  Eligibility for VA 
benefits is based on active military service and discharge or release under conditions other than 
dishonorable (VA, 2015).  Historically, care has focused on male Veterans’ health needs; 
however, in the most recent decade, a growing emphasis has been on women Veterans’ health 
needs.  One focus has been an investment in training the primary care provider (PCP) in 
women’s health, so all primary care needs such as cancer screenings and contraception are 
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accomplished by one provider (Bergman, Frankel, Hamilton, & Yano, 2015).  The majority of 
VA facilities, however, do not provide maternity care.  Maternity care is primarily provided 
through the Non-VA (Fee) Medical Care system (Frayne et al., 2014).  Pregnant women are 
referred by their VA PCP to an outside obstetric provider for their maternity care and the initial 
postpartum visit.  VA pays for this outside care, and it may be at a partner DOD facility or an 
independent community clinic.  Alternatively, women may choose to use their private health 
insurance or Medicaid instead of their VA benefits; creating unique challenges, especially in 
communication between VA and non-VA providers to coordinate pregnancy and postpartum 
care. 
The current VA/DoD Clinical Practice Guideline for Pregnancy Management (VA & 
Department of Defense [DOD], 2009) states all women should be screened for depression at six 
to eight weeks gestation, 28 weeks gestation, and eight weeks postpartum using a standardized 
tool such as the Edinburgh Postnatal Depression Scale (EPDS) or Patient Health Questionnaire 
two question short form (PHQ-2).  This guideline was published seven years before the updated 
USPSTF guidelines and six years before the updated ACOG guidelines.  It is expected that the 
community obstetric providers “follow accepted clinical evidence based standards” (VA, 2012, 
p. 5) which differed before 2015 from the VA/DOD policy.  It is possible that this may have 
caused a gap in PPD screening if outside providers followed previous USPSTF or ACOG 
guidelines.   
Purpose 
The purpose of this project was to evaluate PPD screening practices in accordance with 
current USPSTF and ACOG guidelines and VA/DOD policy.  Using a quantitative approach, the 
data obtained was analyzed for compliance with these guidelines and policy.  The analysis 
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looked for potential differences in care between (a) women seen at a DOD facility versus a 
community facility, (b) women with a history of depression or anxiety versus no history, and (c) 
women with active depression versus those without.  The results were used to guide 
interventions to improve awareness of PPD screening in the AVAHS primary care clinic.   
Literature Review 
 A literature review was conducted to obtain information regarding PPD screening in 
primary care.  Relevant studies and published articles were identified through searches of 
databases including CINAHL Plus with Full-Text, Cochrane Library, PsycINFO, and PubMed.  
Search terms used included: postpartum depression, postnatal depression, screening, risk factors, 
primary care, barriers, treatments, and quality improvement.  Reviewing the reference lists of 
articles found led to additional relevant articles.  The following literature review defines PPD 
and the postpartum timeframe; explains how PPD differs from the baby blues; identifies risk 
factors and consequences of PPD; and summarizes treatment options.  The literature review also 
encompasses PPD screening tools, barriers to screening and methods for improving screening 
rates.  Searching for postpartum depression and Veterans yielded no relevant results, indicating a 
need for future studies. 
Postpartum Depression 
Postpartum depression, as described in the fifth edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5; APA, 2013), is a major depressive episode with a 
peripartum onset.  The diagnostic criteria for a major depressive episode is five or more of the 
following symptoms present during the same two-week period and represent a change from 
previous functioning:  (a) depressed mood most of the day, nearly every day, as indicated by 
either subjective report or observation made by others; (b) markedly diminished interest or 
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pleasure in all, or almost all, activities most of the day, nearly every day; (c) significant weight 
loss when not dieting or weight gain, or decrease or increase in appetite nearly every day; (d) 
insomnia or hypersomnia nearly every day; (e) psychomotor agitation or retardation nearly every 
day; (f) fatigue or loss of energy nearly every day; (g) feelings of worthlessness or excessive or 
inappropriate guilt nearly every day; (h) diminished ability to think or concentrate, or 
indecisiveness, nearly every day; or (i) recurrent thoughts of death, recurrent suicidal ideation 
without specific plan, or a suicide attempt, or a specific plan for committing suicide.  At least one 
of the symptoms is either depressed mood or loss of interest or pleasure.   
Postpartum Depression Timeframe 
The peripartum timeframe is during pregnancy or within four weeks after delivery (APA, 
2013).  The timeframe for onset extends to six weeks after childbirth according to the 
International Classification of Diseases Tenth Edition (ICD-10; WHO, 2016).  Another source 
defines PPD as “any major or subsyndromal depression present any time during the first year 
after delivery” (O’Hara & McCabe, 2013, p. 380).  This same source states PPD “may persist 
over a long period of time, and it is likely to be associated with recurrent depressive episodes” 
(O’Hara & McCabe, 2013, pp. 388).  ACOG recommends screening for PPD during the first 
year postpartum, whereas USPSTF does not identify a specific timeframe (ACOG, 2015; Siu & 
USPSTF, 2016). 
Stowe, Hostetter, and Newport (2005) studied 209 women in Atlanta, Georgia, referred 
for PPD treatment.  They found different timeframes for the onset of symptoms with 11.5% 
during pregnancy, 66.5% during the early postpartum period (delivery to six weeks) and 22% 
during the late postpartum period (six weeks to one year).  A German study (Martini et al., 2015) 
discovered of 306 women, 41 developed peripartum depression with 27 having the first 
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incidence during the postpartum period.  Of the women with PPD, 37.7% developed symptoms 
during the first two months following delivery; 11.1% during months two through four; and 
51.9% from months four through sixteen.   
Baby Blues 
 Postpartum depression differs from the phenomenon of “baby blues” or “postpartum 
blues.” Baby blues refers to the transient symptoms of brief crying spells, irritability, 
nervousness, poor sleep, and emotional reactivity that occur during the first ten days postpartum 
(Sit & Wisner, 2009).  Sit and Wisner (2009) cite that 75% of women are affected by the baby 
blues.  A qualitative study of 68 women in the United Kingdom found 69% to report feelings of 
depression, spontaneous bouts of crying, or both during the first week postpartum (McIntosh, 
1986).   
Buttner, Brock, and O’Hara (2015) followed 216 women in Iowa for the first 14 days 
postpartum and assessed their mood daily.  They found on average, negative affect increased 
daily from delivery, peaked at day five and returned to baseline at day ten.  Positive affect 
declined daily from delivery, stabilizing on day ten.  Women who later developed PPD followed 
the same trajectory of negative and positive affect, but they reported a higher starting level of 
negative affect and a lower starting level of positive affect.   
Risk Factors 
 Risk factors for PPD are numerous.  Although not exhaustive, Table 2 summarizes 
several studies identifying many of these risks.  The most common risk factor identified was a 
history of depression or anxiety (Katon, Russo, & Gavin, 2014; Martini et al., 2015; Milgrom et 
al., 2008; Nguyen et al., 2013).  A history of other mental health disorders such as post-traumatic 
stress disorder (PTSD) or bipolar disorder also increased the risk of PPD (Beck, Gable, Sakala, 
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& Declercq, 2011; Nguyen et al., 2013).  A lack of social support was reported as a risk factor, 
while good social support was noted to be protective (Martini et al., 2015; Milgrom et al., 2008; 
Schachman & Lindsey, 2013).  Maternal age was often mentioned with multiple studies citing 
younger mothers at higher risk of PPD (Bottino, Nadanovsky, Moraes, Reichenheim, & Lobato, 
2012; Katon, Russo, & Gavin, 2014; Nguyen et al., 2013).  Unique studies examined additional 
risk factors of experiencing a natural disaster, infertility, geographic location, quality of sleep, 
history of physical or sexual abuse, history of pregnancy loss, diabetes, and deployment of 
spouse (Akyuz, Seven, Devran, & Demiralp, 2010; Dorheim, Bondevik, Eberhard-Gran, & 
Bjorvatn, 2009; Gaillard, Le Strat, Mandelbrot, Keita, & Dubertret, 2014; Giannandrea, Cerulli, 
Anson, & Chaudron, 2013; Harville, Xiong, Pridjian, Elkind-Hirsch, & Buekens, 2009; Jewell, 
Dunn, Bondy, & Leiferman, 2010; Kozhimannil, Pereira, & Harlow, 2009; Martini et al., 2015; 
Smith, Munroe, Foglia, Nielsen, & Deering, 2010; Spooner, Rastle, & Elmore, 2012). 
 
Table 2 
Risk Factors for Postpartum Depression 
Source Risk factors Sample Study method 
Beck, Gable, 
Sakala, & Declercq, 
2011 
PTSD, low health promoting behaviors, unplanned 
pregnancy, lack of private health insurance, not 
breastfeeding, unemployed, multiparity 
1573 women 
nationally 
Prospective 
longitudinal 
Katon, Russo, & 
Gavin, 2014 
Younger age, unemployment, antenatal depressive 
symptoms, taking antidepressants, psychosocial stressors, 
prepregnancy chronic physical illnesses, smoking 
1,423 women in 
Washington state 
Prospective 
cohort 
Martini et al., 2015 Anxiety or depression before pregnancy, history of sexual or 
physical trauma, low maternal education, operative mode of 
delivery, low social support, low self-esteem 
306 women in 
Germany 
Prospective 
longitudinal 
Milgrom et al., 2008 Antenatal depression, antenatal anxiety, low social support 
levels, history of depression 
12,361 women in 
Australia 
Prospective 
cohort 
Nguyen et al., 2013 Deployment with combat exposure after childbirth, younger 
age, prior mental health disorder, positive PTSD screen, 
Army service 
1,660 U. S. Active 
Duty 
Servicewomen 
Prospective 
longitudinal 
Schachman & 
Lindsey, 2013 
Greater family changes and strains, lower self-reliance, 
lower social support 
71 military wives 
in southeast U.S. 
Comparative 
descriptive 
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Consequences of Postpartum Depression 
The literature agrees that PPD has adverse effects.  The degree of severity of these 
consequences varies.  Poor infant and mother bonding is often cited, but the physical well-being 
and the emotional development of the infant are also affected (Field, 2010; Kingston, Tough, & 
Whitfield, 2012; Ohoka et al., 2014).  There are long-term effects on the mother as well.  A 
woman who suffers from PPD has an increased risk for developing other mental disorders in the 
future and a greater risk of suicidality (Chu, Emasealu, Hu, O’Donnell, & Clark, 2015; Do, Hu, 
Otto, & Rohrbeck, 2013).  The severity of the consequences supports the need for screening, 
diagnosing, and treating PPD. 
Treatment of Postpartum Depression 
 Treatment for PPD includes general counseling, individual or group psychotherapy, 
cognitive-behavioral therapy, and pharmacotherapy.  Excluding pharmacotherapy, therapy for 
PPD is not always delivered by a mental health professional.  Research has shown effective 
interventions administered by visiting home nurses, child health nurses, and case managers with 
bachelor’s degree training (O’Hara & McCabe, 2013).  The most common treatment for PPD is 
antidepressant medication (O’Hara & McCabe, 2013).  When choosing an antidepressant, the 
PCP must know if the woman is breastfeeding.  O’Hara and McCabe report sertraline, 
paroxetine, and nortriptyline as having the best safety profile during lactation (2013).  If not 
breastfeeding, then pharmacotherapy is identical to major depression treatment with selective 
serotonin reuptake inhibitors often chosen first due to their favorable adverse effect profiles and 
relative safety in overdose compared with tricyclic antidepressants (Hirst & Moutier, 2010). 
 Molyneaux, Howard, McGeown, Karia, and Trevillion (2014) conducted a Cochrane 
systematic review of randomized control trials regarding antidepressant treatment for postnatal 
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depression.  They included six trials in their review, with a total of 596 participants.  They 
concluded the evidence base was limited and larger-scale trials were needed.  They estimated 
that selective serotonin reuptake inhibitors were significantly more effective than placebo.  
However, evidence was insufficient to recommend antidepressant use over psychological or 
psychosocial treatments.   
Sockol, Epperson, and Barber (2011) conducted a meta-analysis of treatments for 
perinatal depression.  They looked at studies involving psychological and pharmacological 
interventions, and the studies had to use a prospective pretreatment-posttreatment, quasi-
randomized trial or randomized controlled trial design.  All interventions included saw a 
reduction in symptoms.  They found interpersonal psychotherapy to be superior to cognitive 
behavioral therapy.  Individual psychotherapy had better results than group psychotherapy.  
Additional studies are needed to assess the effectiveness of psychotherapy compared to 
pharmacotherapy.  They also identified the need for more studies assessing long-term outcomes 
of treatment. 
Screening Tools 
There are a variety of validated screening tools for PPD.  ACOG (2015) does not 
recommend a specific screening tool.  They encourage the use of a standardized, validated tool 
such as the EPDS, Postpartum Depression Screening Scale, Patient Health Questionnaire 9, Beck 
Depression Inventory, Beck Depression Inventory-II, Center for Epidemiologic Studies 
Depression Scale, or Zung Self-rating Depression Scale.  Haran et al. (2014) compared 
guidelines regarding postpartum care from around the world.  They found two Australian 
guidelines, Beyondblue and Royal Australian College of General Practitioners, recommending 
the use of the EPDS for PPD and anxiety screening due to its well documented high sensitivity 
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and specificity.  In contrast, Haran et al. (2014) also looked at the National Institute for Health 
and Clinical Excellence guidelines which did not recommend using the EPDS as a screening tool 
for PPD.  Instead, they recommended relying on professional judgment and clinical interview, 
where the EPDS could serve as part of the assessment.  The USPSTF, the American Academy of 
Pediatrics, and the American Academy of Family Physicians all report the EPDS as a commonly 
used and well-validated depression screening tool (Siu & USPSTF, 2016; Earls, 2010; Hirst & 
Moutier, 2010).  The World Health Organization (WHO) does not endorse a specific screening 
tool.  They state women should be asked about their emotional well-being at each postnatal 
contact and encouraged to tell their health care provider about any changes in mood, emotional 
state, and behavior that are outside their normal patterns (WHO, 2013). VA and DOD 
recommend using the EPDS or the PHQ-2 to screen for PPD (VA/DOD, 2009).  Both of these 
tools have extensive research supporting their use.  See Appendix A and B for an example of 
each tool. 
Edinburgh Postnatal Depression Scale (EPDS).  The EPDS is a ten-item self-report 
scale for PPD screening which assesses depressive symptoms experienced over the prior seven 
days including anhedonia, depressed mood, and suicidality (Cox, Holden, & Sagavosky, 1987; 
Cutler et al., 2007).  It has been in use since the 1980s and validated in multiple languages.  It 
was developed as a self-report scale and does not require the health care worker to have any 
specialist knowledge of psychiatry (Cox et al., 1987).  It was initially validated against 
Goldberg’s Standardised Psychiatric Interview using the Research Diagnostic Criteria of Spitzer 
for depressive illness.  The EPDS is scored out of 30 possible points.  The initial validation study 
included 84 mothers and used a 12/13 threshold score with a score of 13 or more indicating a 
positive depression screen.  Results demonstrated 86% sensitivity and 78% specificity with 0.88 
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split-half reliability with standardized α-coefficient 0.87 (Cox et al., 1987).  O’Connor, Rossom, 
Henninger, Groom, and Burda (2016) systematically reviewed 23 studies of the EPDS using the 
same cutoff score of 13 on the English-language EPDS.  They found sensitivity ranging 67% to 
100% and specificity ranging 87% to 99%.  Gjerdingen and Yawn (2007) recommend using the 
EPDS as it was the most extensively studied PPD screen yielded by their literature review of 
OVID/MEDLINE and the Cochrane database.  Additionally, it is validated for use during 
pregnancy with sensitivity and specificity ranging between 64-100% and 73-100%, respectively 
(Kozinszky & Dudas, 2015).   
 Patient Health Questionnaire-2 (PHQ-2).  The PHQ-2 is another depression screening 
tool that was designed to be self-administered.  It consists of the first two questions of the Patient 
Health Questionnaire-9 that inquire about the frequency of depressed mood and anhedonia over 
the past two weeks (Kroenke, Spitzer, & Williams, 2003).  Although originally developed to 
screen for major depressive disorder, Cutler et al. (2007) found the PHQ-2 to have a sensitivity 
of 43.5% and specificity of 97.2% for PPD using the EDPS as a reference scale.  Gjerdingen, 
Crow, McGovern, Miner, and Center (2009) used the Structured Clinical Interview for DSM-IV 
as a reference point and found the PHQ-2 to have a sensitivity of 75% and specificity of 88% for 
PPD.  Bennett et al. (2008) studied the validity of the PHQ-2 antepartum and postpartum.  The 
PHQ-2 had a sensitivity of 93%, 82%, and 80% and a specificity of 75%, 80%, and 86% at 15 
weeks gestation, 30 weeks gestation and postpartum, respectively.  Criterion validity and 
construct validity were found favorable in both primary care clinics and obstetrics-gynecology 
clinics (Kroenke et al., 2003).  Internal consistency reliability for the PHQ-2 was 0.88 in a large 
national survey of postpartum women (Beck et al., 2011).   
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Barriers to Screening 
 Byatt et al. (2012) conducted focus group interviews with a variety of perinatal health 
care professionals to identify barriers and facilitators to addressing perinatal depression.  They 
identified patient, provider, and system-level barriers.  Patient-level included: “complex 
psychosocial factors and stigma result in limited initiative to seek treatment” (p. 438); and 
“women are concerned about the risk of antidepressant use during the perinatal time period” (p. 
439).  Provider-level included: “limited resources, motivation and confidence” (p. 440); and 
“limited mental health training and knowledge” (p. 440).  Finally, system-level included: 
“limited access to mental health care” (p. 441); and “lack of communication and continuity 
between perinatal and mental health professionals” (p. 441). 
 Gjerdingen and Yawn (2007) searched available literature in the OVID/MEDLINE and 
the Cochrane databases and found patient-centered, physician-centered, and systems barriers to 
be the three general types of barriers to effective PPD diagnosis and treatment.   
Patient-centered variables include cost and lack of insurance coverage, time constraints, 
social stigma, nonadherence to depression treatment, lack of follow-through with mental 
health referrals, and lack of access to care for various reasons.  Physician-centered 
variables include lack of time, managed care policies, competing demands, insufficient 
training/knowledge, insurance or payment problems, and fear of legal repercussions.  
Systems based variables also play a role and include infrequent follow-up visits for 
mothers, lack of objective, proactive monitoring of recovery, and separation of primary 
care and mental health services.   
In addition, mothers of infants may experience barriers that are unique to the 
postpartum or early child-rearing period, such as need for childcare during mental health 
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visits, concern about medication effects on nursing infants, and fear of judgement and 
referral to child protection.  (p. 285) 
 Bilszta, Ericksen, Buist, and Milgrom (2010) conducted a qualitative focus group study 
in Australia with health professionals involved in the care and treatment of women with postnatal 
emotional distress.  They found the EPDS to be a simple and comfortable tool to use in 
diagnosing depression.  However, women who were mildly depressed were harder to recognize.  
A large area of need they discovered was a need for further information and support to develop 
interdisciplinary and interagency collaborations among service providers for screening and 
treatment of perinatal emotional distress.   
 Delatte, Cao, Meltzer-Brody, and Menard (2009) surveyed provider attitudes and practice 
following the implementation of a universal screening protocol for PPD at the six-week 
postpartum visit.  Providers were to use the EPDS to screen women.  If women scored less than 
10, no further action was needed; a score of 10-12 prompted the provider to counsel the patient 
and provide an educational pamphlet; a score of 13 or more prompted the provider to assess the 
need for treatment with medication, counseling or immediate psychiatric referral.  Their chart 
audit included 458 women seen over a four and a half month period.  Only 39% of the charts had 
an EPDS score documented, and only 35% had documentation that women were counseled on 
their score or depression.  There was a significant difference in compliance with screening 
dependent on the type of provider with nurse practitioners documenting universal screening 
94%, certified nurse midwives 67%, attendings 42% and residents 17% of the time.  They also 
sent a survey to providers with a 77% response rate.  Diagnosing PPD was not a significant 
barrier as 94% reported feeling confident with diagnosing.  However, only 76% were confident 
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with initiating treatment with medications, and only 70% were confident in providing counseling 
and education about PPD (p. e64).   
Improving Postpartum Depression Screening 
The Translating Research into Practice for Postpartum Depression (TRIPPD) study was a 
large U. S. based effectiveness study of screening and follow-up care for PPD (Yawn et al., 
2012).  It compared usual care with staff education on a multistep PPD screening and diagnosis 
process using the EPDS and PHQ-9.  The intervention sites received tools to facilitate diagnosis, 
follow-up, and management of PPD.  The researchers enrolled 2,343 women at 28 practice sites.  
Diagnosis, therapy initiation, and referrals for psychiatric care for PPD were significantly more 
likely among women in the intervention group.  This study used the EPDS scale to screen for 
depression and if positive, continued with the PHQ-9 and physician evaluation.  The main 
therapy used was an antidepressant medication with follow-up phone calls by nursing staff and 
follow-up office visits.  Although the data did not reach statistical significance, the intervention 
group had higher rates of improvement from depression than the usual care group suggesting 
clinical significance.   
Researchers have examined the effectiveness of PPD screening through means of 
telephone interviews.  Hanusa, Scholle, Haskett, Spadaro, and Wisner (2008) found the EPDS to 
be an efficient means of screening postpartum women.  They offered home visits to follow up on 
positive depression screening.  Seventy-three percent of women with positive screenings agreed 
to home visits, and 45% of these women were found to meet the criteria for a major depressive 
disorder based on Diagnostic Interview Schedule.  Another study used an automated voice 
response system to administer the EPDS.  They found PPD symptoms in 17% of women who 
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called in; however, those who did not call in, could not be determined not to have PPD (Kim et 
al., 2012). 
 The Partnership for Women’s Health (PWH) model was designed for and implemented in 
obstetric and pediatric offices in San Diego, California, to improve screening and treatment of 
PPD (Baker-Ericzén, Mueggenborg, Hartigan, Howard, & Wilke, 2008).  The model addresses 
physician barriers through a collaborative approach.  Mothers are screened for PPD at routine 
postpartum visits, and proactive follow-up is done by a mental health advisor for linkage to 
treatment.  Providers and staff were trained on the PWH model and how to assess for PPD using 
the EPDS.  Protocols were in place to address suicidality if reported on the EDPS or during the 
visit.  For positive screenings, EPDS score greater than or equal to 10, providers were trained to 
reassure the mothers and inform them a mental health advisor would contact them soon to 
facilitate a link to treatment.  All mothers received an educational handout on maternal 
depression, and those with positive depression screens also received a list of local resources.  
The mental health advisor contacted women within 48 hours and assisted in linking the women 
to treatment.  During a one-year pilot trial of the PWH program, 718 women were screened for 
PPD, and 116 women had positive screens.  The mental health advisor was able to make contact 
with 109 of those women.  Mothers were surveyed for satisfaction with the program.  Ninety-
eight percent of mothers (n=83) reported being satisfied with the program assistance.  Providers 
were surveyed at baseline and the end of the one-year pilot.  Providers had increased frequency 
of screening and increased awareness of community resources for PPD. 
 The Stepped Care Treatment of Postpartum Depression randomized controlled trial used 
a stepped care treatment of PPD model (Gjerdingen, Katon, & Rich, 2008).  In this trial, all 
women were routinely screened for PPD with their PCP or at their infant’s well-child visits.  The 
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screening was done with standardized tools such as the PHQ-9 or EPDS.  Positive screens were 
followed up with a diagnostic survey or interview to confirm the diagnosis of depression.  Patient 
education was initiated at the time of screening and diagnosis.  The initial treatment plan was 
developed between the mother and her PCP and may include psychological and pharmacological 
interventions.  Persistent or complicated illness was referred to a mental health specialist who 
was available in the primary care setting.  Higher levels of specialty care were initiated in severe 
disease or presence of suicidality.  Follow-up care was performed during regular office visits or 
through telephone calls which may be made by case managers.  This clinical trial was still in 
progress at the time of publishing, but preliminary results supported its use in PPD (Gjerdingen 
et al., 2008). 
 Loudon, Nentin, and Silverman (2015) implemented a clinical decision support “hard 
stop” (p. 1) to the electronic health record at Mount Sinai Hospital OB/GYN Ambulatory 
Practice in New York.  All providers were required to enter a standardized PPD mood 
assessment score into the patient’s chart before closing it.  They used the EPDS as the 
standardized tool.  Of the 2102 women seen for postpartum visits, 2092 women completed the 
EPDS.  The ten who did not complete the screening had reasons identified as (a) language 
barrier, (b) refusal to complete or (b) no documented reason.  Although this study supported the 
use of a hard stop in the electronic medical record to identify PPD, it did not address follow-up 
treatment.   
Literature Review Summary 
Postpartum depression is a common complication during the postpartum period and can 
occur for a full year after delivery.  Known risk factors include a history of depression or 
anxiety, lack of social support, and post-traumatic stress disorder.  If left untreated, PPD has 
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adverse effects on both the mother and child.  It can be effectively identified in the primary care 
setting using standardized tools.  Initial treatment is most effective when initiated in the primary 
care setting and can be psychological, pharmacological or both.  Educating and providing health 
care providers with standardized tools and appropriate treatment options for positive PPD 
screens increases the quality of care.   
Implications for Nursing Practice 
Myers et al. (2013) reported on the efficacy and safety of screening for PPD.  They state 
“the potential effectiveness of screening for postpartum depression appears to be related to the 
availability of systems to ensure adequate followup of women with positive results” (p. ix).  As 
PCPs, advanced practice nurses are capable of screening for PPD and providing first line 
treatment (Hirst & Moutier, 2010).  Both the EPDS and the PHQ-2 are self-administered 
screening tools and do not require specialized training of the health care worker.  Therefore, the 
advanced practice nurse can delegate the PPD screening to other members of the patient aligned 
care team such as the registered nurse or licensed practical nurse.  As the PCP diagnosing the 
pregnancy and referring the woman to an obstetric provider, the advanced practice nurse can 
provide anticipatory guidance to the patient and educate her on the available resources within 
VA for PPD, along with discussing preemptive treatment plans for women with a known history 
of PPD. 
Methods 
Quality Improvement 
Massoud et al. (2001) stated the purpose of quality improvement (QI) is to identify 
“where gaps exist between services actually provided and expectations for services.  It then 
lessens these gaps not only to meet customer needs and expectations, but to exceed them and 
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attain unprecedented levels of performance” (p. 3).  It does not necessarily require adding new 
resources, rather, QI involves making changes in an organization to make the best use of 
resources already available.   
There are a variety of QI approaches and methods.  These approaches include individual 
problem solving, rapid team problem solving, systematic team problem solving, and process 
improvement.  There are four basic steps to all methods of QI: (a) identify, (b) analyze, (c) 
develop, and (d) test and implement.  Identify is determining the process to improve.  Analyze is 
understanding the multiple facets of the problem.  Develop is hypothesizing about what changes 
will improve the problem.  The fourth step is testing the hypothesized solution on a small scale to 
see if it yields improvement.  Then, based on the results, the improvement is abandoned, 
modified, or implemented on a large scale.  This last step can be a continuous process of plan, 
do, study and act.   
Project Design 
 Methodology.  The first step in QI is to identify what needs improvement.  New 
screening guidelines for PPD and a growing female Veteran population presented an area where 
improvement may be necessary.  The second step in this QI project was to analyze current PPD 
screening practice at the AVAHS.  A medical record audit was executed and is described in 
detail in the data collection section.  The third step in QI is to develop a hypothesis based on the 
multiple facets of the problem identified through the analysis phase and current research of what 
changes will lead to process improvement.  The fourth step is to test the intervention.  The goal 
of this project was to identify whether a problem exists with conducting universal PPD screening 
and referral of female Veterans in Alaska.  If the findings supported a need for intervention, then 
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a viable intervention would be presented to the AVAHS for consideration and implementation 
testing.   
 Population.  Women Veterans eligible for VA health benefits are women who served in 
the active military service and were discharged or released under conditions other than 
dishonorable (VA, 2015).  In the fiscal year 2014, 10,192 women Veterans were living in the 
State of Alaska.  Of those women, 4,402 were between ages 18-44 years (VA, National Center 
for Veterans Analysis and Statistics, 2014).  Health care professionals working within the 
AVAHS primary care clinic include physicians, nurse practitioners, registered nurses, licensed 
practical nurses, and social workers. 
Data Collection 
 Sample.  The entire cohort of women Veterans enrolled in the AVAHS who had a 
maternity consult placed for the purpose of pregnancy during the FY 2014 was included.  The 
FY 2014 ran from October 1, 2013, through September 30, 2014.  This chosen timeframe 
allowed for at least one year to pass from the date of delivery to the date of data collection.  A 
one-year postpartum timeframe is used by most researchers and ACOG, as described in the 
literature review. 
The AVAHS Women Veterans Program Manager provided the list of patient names.  
Through a previous conversation with her, this was estimated to be 25 to 30 women.  The final 
list included 32 women.  Exclusion criteria were: (a) women under the age of 18 at the time of 
delivery; (b) maternity consults for any reason other than pregnancy; (c) women leaving the state 
before delivery; and (d) fetal demise.  In reviewing the literature, PPD researchers typically 
excluded women who had an active diagnosis of depression at the time of pregnancy.  These 
POSTPARTUM DEPRESSION SCREENING  28 
women were not excluded from this project because analysis of their postpartum care could have 
helped guide interventions for routine PPD screening and care. 
 Medical record audit.   Retrospective medical record audits were conducted by myself 
as the sole investigator.  As an employee of the AVAHS, I had access to, and training in, the 
electronic health record, Computerized Patient Record System (CPRS).  Audits were conducted 
during non-paid hours only over a one week period.   
A standardized approach was used due to differences in charting with some providers 
using templates and others free-typing or dictating their clinic notes.  First, I located the obstetric 
consult, then the hospital notification of the delivery date.  Next, I scanned outside records for 
postpartum notes after the delivery date.  I looked at the problem list for a diagnosis of 
depression or anxiety, and lastly, I used the word search option in CPRS for “depression” and 
“anxiety” to locate relevant documentation.   
Data was recorded on paper audit forms.  Information was collected on: (a) type of 
obstetric provider, (b) presence of active depression, (c) history of depression or anxiety, (d) 
occurrence of PPD screening, (e) where screening occurred, (f) who performed the screening, (g) 
timing of screening, (h) what screening tool was used, (i) screening results, (j) was treatment and 
where, (k) when was the first contact between the woman and the AVAHS primary care clinic 
after delivery, (l) who initiated contact, and (m) when was her first primary care appointment 
after delivery. Socioeconomic risk factors such as income, education level, and marital status, 
were not easily found in CPRS and therefore not recorded.  The questions asked in the medical 
record audit were developed from risk factors identified in the literature review, the updated 
screening guidelines, and VA/DOD policy.  See Appendix C for example of audit form.  After 
starting the chart audits, I also decided to record if the woman’s PCP was located at the VA 
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clinic or in the community. As with community obstetric providers possibly having different 
screening policies than the VA, community PCPs may also be different.   
Data Analysis  
After data were collected on paper audit forms, I transcribed the data into SPSS, a 
computer-based statistical software program.  The majority of data collected  were nominal level 
and was first analyzed with descriptive statistics to summarize the frequency of the answers to 
each question on the audit form.  The proposal plan included using the nonparametric chi-square 
test to look for differences in PPD screening rates between different sample characteristics: (a) 
DOD versus community obstetric provider, (b) history of depression or anxiety versus no history 
of depression or anxiety, (c) active depression during pregnancy versus no active depression, and 
(d) VA versus community primary care provider.  Secondary to a violation of expected 
frequencies test assumption and incomplete data, chi-square analysis was not completed.   
Theoretically, if no improvement was needed in current practice, all medical records 
audited would include PPD screening.  In the actual world of health care, 100% compliance is 
difficult to achieve.  I chose a cutoff of 95% compliance to indicate no need for improvement.  If 
PPD screening was a key quality measure for The Joint Commission (TJC), then 95% 
compliance would earn a “top performer” designation (TJC, 2016). 
Data Dissemination 
Zephyrin et al. (2014) reported VA health care providers need enhanced knowledge of 
psychiatric disorders and how their treatments affect women who are pregnant, postpartum, or 
may become pregnant.  The results of this project will be shared with the providers and nursing 
staff in the AVAHS primary care clinic.  In fulfillment of the Master’s degree requirements at 
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the University of Alaska Anchorage, the results will also be presented in poster format at a 
professional conference.   
Ethical Considerations 
Confidentiality.  Data was de-identified by keeping patient identifiers on a separate sheet 
of paper from the audit forms; allowing me to keep track of which medical records I had already 
reviewed and prevent duplication.  The names of the health care providers were not recorded to 
maintain privacy and prevent any possible retaliation.  All electronic information was stored on a 
password-protected thumb drive.  The SPSS program was accessed on my personal computer 
which was password protected.  The thumb drive, paper audit forms, and list of patient names 
will be secured in a locked safe in my home for the duration of the project and an additional 
three years.  At that future time, they will be destroyed by fire.   
Institutional Review Board.  Facility approval was received from the AVAHS Medical 
Center Director to conduct this project at the AVAHS after the VA Portland Health Care System 
Institutional Review Board (IRB) had determined it was not research.  The IRB Request for 
Determination of Human Subjects Research form was also completed and submitted to the 
University of Alaska IRB.  Both IRBs determined this project did not meet the qualifications for 
human subject research.  See Appendices D and E for the completed forms. 
Conflicts of interest.  As an employee of the AVAHS, I may have been personally 
involved in the care of a Veteran whose medical record I audited.  To avoid bias, no employee 
names were recorded.  To ensure the integrity of the data, I kept foremost the goal of providing 
excellent care to our female Veterans.   
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Results 
 There were 32 obstetric consults ordered at AVAHS during the fiscal year 2014.  All 
were for women over age 18 years, and all were for the purpose of pregnancy.  Three were 
excluded due to moving out of state during the pregnancy, and four were excluded for fetal 
demise.  An additional four charts were excluded because although an obstetric consult was 
placed, the women elected to use other insurance.  For these women, VA was not notified of the 
birth of the infant, and therefore, I was unable to determine if the pregnancy was carried to term.  
The remaining 21 records were used for analysis.   
 The sample was divided nearly in half by type of obstetric provider and PCP. More than 
three-fourths of the women had a history of depression or anxiety which included women with 
current depression.  Table 3 lists the sample characteristics.  A total of 17 women, or 81%, were 
screened for PPD.  The remaining four women had no documentation of PPD screening.  These 
women were also assigned to a community PCP.  Through this audit, it could not be determined 
with certainty if the screening had not been done versus the documentation of screening had not 
been submitted to the VA.  The data was incomplete due to the possibility of missing records.  
  
Table 3 
Sample Characteristics (N=21) 
Note. DOD = Department of Defense; VA = Department of Veterans Affairs 
aCurrent diagnosis of depression during pregnancy. 
bPrimary care provider assigned by VA. 
Variable n (%)  Variable n (%) 
Obstetric provider   Primary care providerb  
     DOD 9 (42.9)       VA 12 (57.1) 
     Community 12 (57.1)       Community 9 (42.9) 
Active depressiona   History of depression or anxiety  
     Yes 8 (38.1)       Yes 16 (76.2) 
     No 13 (61.9)       No 5 (23.8) 
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 The 17 records with PPD screening documented were used for further analysis of how the 
screening was completed and are summarized in Table 4.  Five women screened positive for 
PPD, and all were treated or referred for treatment.  Of women only assigned to a VA PCP, there 
was 100% compliance with PPD screening, n=12.  Of the nine women outsourced to a 
community PCP, five had documented PPD screening.  The data was incomplete for the 
remaining four women with a community PCP.  The most frequently documented screening tool 
was the PHQ-2, found in 11 records.  Other tools used were the EPDS, PHQ-9, and clinical 
interview.   
 
Table 4 
Characteristics of Completed Postpartum Depression Screenings (n=17) 
Note. VA = Department of Veterans Affairs; APRN = Advanced practice registered nurse; EPDS = Edinburgh Postnatal 
Depression Scale; PHQ-2 = Patient Health Questionnaire two question form 
 
 
Variable n (%)  Variable n (%) 
Where screening occurred   Screening tool used  
     VA 11 (64.7)       EPDS 3 (17.6) 
     Obstetric provider 5 (29.4)       PHQ-2 11 (64.7) 
     Other 1 (5.9)       Other 3 (17.6) 
Who performed screening   Result of screening  
     Nurse 7 (41.2)       Positive 5 (29.4) 
     APRN 1 (5.9)       Negative 12 (70.6) 
     Physician 2 (11.8)  Who initiated treatment n = 5 
     Social worker 2 (11.8)       Obstetric provider 1 (20.0) 
     Unable to determine 5 (29.4)       Primary care provider 2 (40.0) 
When was screening performed        Other 2 (40.0) 
     0 to 2 weeks 2 (11.8)    
     2+ to 6 weeks 5 (29.4)    
     6+ to 12 weeks 2 (11.8)    
     12+ to 52 weeks 8 (47.1)    
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The majority of women Veterans had contact with the VA primary care clinic during the 
first year postpartum.  The Veteran initiated this contact more often than the VA clinic staff.  
Table 5 further describes the contact after delivery between the woman Veteran and the VA 
clinic.   
 
Table 5 
Characteristics of How Women Reengaged with Primary Care after Childbirth (N=21) 
Note. VA = Department of Veterans Affairs; PCP = primary care provider 
 
Discussion 
 There was 29.4% prevalence of positive PPD screens found in this audit which is 
congruent with previously reported estimates of PPD prevalence.  This reinforces that PPD is a 
common condition and warrants VA attention.  It was pleasing to find PPD screening occurred at 
least once in the first year after childbirth for women assigned to a VA PCP.  Likely contributing 
to policy and guideline compliance was the use of a clinical reminder to screen for depression 
Variable n (%)  
When was first contact with VA clinic   
     0 to 6 weeks 12 (57.1)  
     6+ to 12 weeks 5 (23.8)  
     12+ to 52 weeks 2 (9.5)  
     None 2 (9.5)  
Who initiated contact between Veteran and VA clinic   
     Veteran 13 (61.9)  
     VA staff 3 (14.3)  
     Unable to determine 3 (14.3)  
     No contact initiated 2 (9.5)  
When was first visit with VA authorized PCP   
     0 to 6 weeks 4 (19.0)  
     6+ to 12 weeks 4 (19.0)  
     12+ to 52 weeks 10 (47.6)  
     None 3 (14.3)  
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annually, VA policy for women to be seen within three months of delivery, and continuity of 
care arranged by the same health care provider.  The literature review identified using clinical 
reminders and continuity of care as beneficial to improving rates of PPD screening, and the 
results support these continued practices.   
 The medical records audited were for pregnancies before the updated ACOG and 
USPSTF guidelines on universal PPD screening were released.  The VA/DOD policy on 
universal screening was published before the timeframe audited.  A greater percentage of women 
with a DOD obstetric provider had documentation of screening compared to a community 
obstetric provider, 88.9%, and 75.0%, respectively.  Missing records impeded statistical 
comparison; however, differing guidelines might explain some of the difference in screening 
rates.  An area of future quality improvement might look at the obstetric consults placed during 
the FY 2017, after the publication of the updated national guidelines.   
All the women with missing documentation of PPD screening were outsourced to a 
community provider for primary care.  From the information available in the VA electronic 
medical record, it could not be determined if the women were not screened versus incomplete 
documentation in the VA medical record.  Three of the four women with missing PPD screening 
had documentation of at least one postpartum visit with their community PCP which could have 
been a missed opportunity for screening. However, there was no way of knowing from this audit 
if they only had the one visit. The four women who used other insurance also had no 
documentation of PPD screening in their VA medical record.  The missing records were an 
example of the lack of communication and continuity of care between obstetric providers and 
PCPs.  Previous research identified these as known system-level barriers.  Addressing these 
system barriers are grounds for future projects on this topic.   
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Intervention Development 
The literature review identified several strategies to improve PPD screening rates: (a) 
telephone calls to new mothers, (b) educating new mothers, (c) educating health care providers 
(d) providing health care providers with algorithms for PPD screening and care, (e) having a 
dedicated mental health provider follow up with positive screens, and (f) using hard stops in the 
electronic health record.  I reviewed these strategies and the audit results with the AVAHS 
Women Veterans Program Manager.  We decided an informational brochure specifically on PPD 
would be beneficial for women Veterans and their health care providers.  The brochures would 
address both patient and provider-level barriers to screening.  By providing education on 
postpartum depression and available local and online resources, the brochures help break down 
patient-level barriers such social stigma, lack of access to care, and time constraints.  Lack of 
knowledge and limited resources were identified as provider-level barriers in the literature 
review.  The brochure will serve as a tool for clinicians to be more aware of PPD, how to screen 
for it, and treatment resources for their women Veteran patients in Alaska.  See Appendices F 
and G for examples of the patient and provider brochures, respectively.   
The brochures are in the process of being approved for use at the AVAHS.  Once 
approved and distributed, the Women Veterans Program Manager is planning to share the 
brochures as examples of best practice with the Northwest Veterans Integrated Service Network 
(VISN 20).  VISN 20 includes VA facilities in Alaska, Idaho, Oregon, and Washington. 
Limitations 
 Small sample size was a major limiting factor in the statistical analysis of this medical 
record audit.  Future audits should consider expanding the timeframe reviewed to increase the 
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sample size.  However, medical practice is fluid, and as new evidence-based recommendations 
develop, the audit may reveal differences due to providers updating their practice. 
 Missing medical records were a limiting factor.  The incomplete data impeded statistical 
analysis.  The four women missing PPD screening, also, did not have postpartum obstetric 
provider notes in the VA medical record.  They may have been screened; however, VA was not 
informed.  Of course, the records would also be missing if the women never returned for 
postpartum care.  Either way, the VA clinic was not notified.   
Conclusion 
 Postpartum depression is a common condition of the first year after childbirth having 
adverse effects on the mother, child, and family.  National guidelines have been updated recently 
recommending universal screening of all women for earlier identification and treatment.  A 
review of current PPD screening practices in the AVAHS revealed current policies are helping to 
ensure all women established in the VA primary care clinic receive screening.  The gap in PPD 
screening between VA and community providers was evident, along, with the women not 
established at the AVAHS primary care clinic.  Through this project, brochures were created to 
help bridge this gap and engage women Veterans in available resources.   
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Appendix A 
Example of Edinburgh Postnatal Depression Scale 
(UCSF Fresno Center for Medical Education and Research, n.d., 
http://www.fresno.ucsf.edu/pediatrics/downloads/edinburghscale.pdf) 
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(UCSF Fresno Center for Medical Education and Research, n.d., 
http://www.fresno.ucsf.edu/pediatrics/downloads/edinburghscale.pdf)  
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Appendix B 
Example of Patient Health Questionnaire-2 
        
(VA/DOD, 2016, p. 22) 
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Appendix C 
Example of Medical Record Audit Form 
  
Postpartum Depression Screening 
Medical Record Audit 
1. Obstetric provider:     DoD  ☐     Community  ☐ 
2. Active depression:     Yes  ☐     No  ☐ 
3. History of depression or anxiety:     Yes  ☐     No  ☐ 
4. Screened for PPD:     Yes  ☐     No  ☐ 
5. Where:     VA  ☐     OB  ☐     Other:____________________ 
6. Screener:     Nurse  ☐     APRN  ☐     Physician  ☐     Other:____________________ 
7. When:  0 to 2 weeks  ☐     2+ to 6 weeks  ☐     6+ to 12 weeks  ☐     12+ to 52 weeks  ☐ 
8. Screening tool:     EPDS  ☐     PHQ-2  ☐     Other:____________________ 
9. Positive PPD screen:     Yes  ☐     No  ☐ 
10. Initial treatment:     OB  ☐     VA PCP  ☐     Other:____________________ 
11. First contact with VA PCC:             
 0 to 6 weeks  ☐     6+ to 12 weeks  ☐     12+ to 52 weeks  ☐     >1 year  ☐ 
12. Who initiated contact:     Patient  ☐     VA staff  ☐ 
13. First visit with VA PCP:             
  0 to 6 weeks  ☐     6+ to 12 weeks  ☐     12+ to 52 weeks  ☐     >1 year  ☐ 
Abbreviations: DoD=Department of Defense; PPD=postpartum depression; VA=Department 
of Veterans Affairs; OB=obstetric provider; APN=advanced practice nurse; EPDS=Edinburgh 
Postnatal Depression Scale; PHQ-2=Patient Health Questionnaire-2 question form; 
PCP=primary care provider; PCC=primary care clinic 
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Appendix D 
Documentation of Support from Alaska VA Healthcare System 
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Appendix E 
University of Alaska Institutional Review Board Determination 
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Appendix F 
Example of Patient Brochure 
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Appendix G 
Example of Provider Brochure 
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